Nevena Arsenović-Ranin

Nevena Arsenović-Ranin

Auto-generated profile, based on publicly available information

Nevena Arsenović-Ranin

NEMA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Experimental Gerontology
Verified
Journal Article
Closed access
GLGordana Leposavić
Gordana Leposavić
VPVesna Pešić
Vesna Pešić
DKDuško Kosec
Duško Kosec
KRKatarina Radojević
Katarina Radojević
NANevena Arsenović-Ranin
Nevena Arsenović-Ranin
BPBosiljka Plećaš-Solarović
Bosiljka Plećaš-Solarović

1 January 2024 in Arhiv za farmaciju
Verified
Journal Article
Open access
PDF file
Dragana D. BozicDragana D. Bozic
Dragana D. Bozic
MTMarina T.Milenković
Marina T.Milenković
JSJelena Stankovoc
Jelena Stankovoc
NANevena Arsenović-Ranin
Nevena Arsenović-Ranin
Biljana BufanBiljana Bufan
Biljana Bufan
The normal human microbiota, formerly called the "microbial flora," consists of bacteria, fungi, viruses, and parasites that colonise the skin and mucous membranes of the respiratory, gastrointestinal, and genitourinary tracts. The number and diversity of microorganisms varies between different body niches and is greatest in the intestinal tract. The microbiota contributes to the homeostasis of the human organism by preventing colonisation by pathogenic microorganisms, participating in digestive processes and metabolism, and regulating immune functions. Various environmental and genetic factors can lead to an imbalance in the human microbiota, called dysbiosis, which can affect human health. Dysbiosis is usually the result of decreased microbial diversity and a lower number of saprophytic microorganisms, followed by an overgrowth of opportunistic species. The most common diseases directly related to intestinal dysbiosis are antibiotic-associated diarrhoea and pseudomembranous colitis, both of which are associated with the excessive growth of harmful bacteria and Clostridioides difficile following broad-spectrum antibiotic therapy. Dysbiosis is associated with various health conditions or diseases such as acne, psoriasis, eczema, chronic obstructive pulmonary disease, inflammatory bowel disease, obesity, metabolic syndrome, type 2 diabetes, autoimmune diseases and allergies, neurological diseases such as Parkinson's disease, Alzheimer's disease, epilepsy and stroke, depression, anxiety, infertility, preterm birth, and malignancies.

1 November 2021 in Immunology Letters
Verified
Journal Article
Closed access
ZSZorica Stojić-Vukanić
Zorica Stojić-Vukanić
IPIvan Pilipović
Ivan Pilipović
NANevena Arsenović-Ranin
Nevena Arsenović-Ranin
MDMirjana Dimitrijevic
Mirjana Dimitrijevic
GLGordana Leposavić
Gordana Leposavić

1 January 2024 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
Dragana D. BozicDragana D. Bozic
Dragana D. Bozic
NANevena Arsenovic-Ranin
Nevena Arsenovic-Ranin
IJIvan Jancic
Ivan Jancic
JSJelena Stankovoc
Jelena Stankovoc
MTMarina T.Milenković
Marina T.Milenković
Biljana BufanBiljana Bufan
Biljana Bufan

1 January 2019 in Arhiv za farmaciju
Verified
Journal Article
Open access
PDF file
NANevena Arsenović-Ranin
Nevena Arsenović-Ranin
Vaccines are considered to be one of the greatest public health achievements of the last century. As a result of widespread vaccine use, the smallpox virus has been completely eradicated and the incidence of other diseases such as polio, measles, tetanus and diphtheria has been drastically reduced. Current licensed vaccines, predominantly composed of either live attenuated or killed pathogens, pathogen subunits, owe their success to their ability to elicit neutralizing antibodies against pathogens. On the other side, cell-mediated immunity, which plays a central role in elimination of intracellular pathogens (which in most cases leads to chronic infections) is much more difficult to obtain using current vaccines. Currently, numerous vector and nucleic acid (DNA and mRNA)-based prophylactic vaccines, capable of inducing substantial vaccine-specific T cell responses, are investigated in preclinical and clinical studies, with promising results. This review focuses the background of vector and nucleic acid-based vaccines, their strengths and weaknesses and safety issues.